Friday, November 25, 2011

FXN methylation predicts expression and clinical outcome in friedreich ataxia

Annals of Neurology, Accepted manuscript online: 25 NOV 2011 08:37AM EST | DOI: 10.1002/ana.22671

Marguerite V. Evans-Galea, Nissa Carrodus, Simone M. Rowley, Louise A. Corben, Geneieve Tai, Richard Saffery, John C. Galati, Nicholas C. Wong, Jeffrey M. Craig, David R. Lynch, Sean Regner, Alicia F. D. Brocht, Susan L. Perlman, Khalaf O. Bushara, Christopher M. Gomez, George R. Wilmot, Lingli Li, Elizabeth Varley, Martin B. Delatycki and Joseph P. Sarsero

Keywords: Friedreich ataxia (FRDA), expanded GAA repeat, frataxin, epigenetic, clinical parameters, DNA methylation, age of onset, Friedreich Ataxia Rating Scale, disease severity, biomarker.